Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$161.02 - $206.98 $1.29 Million - $1.65 Million
-7,985 Reduced 37.91%
13,079 $2.64 Million
Q1 2024

May 13, 2024

BUY
$163.6 - $209.11 $3.45 Million - $4.4 Million
21,064 New
21,064 $3.61 Million
Q3 2023

Nov 14, 2023

BUY
$154.67 - $290.89 $1.27 Million - $2.38 Million
8,196 Added 100.44%
16,356 $2.61 Million
Q2 2023

Aug 11, 2023

BUY
$272.48 - $330.23 $2.22 Million - $2.69 Million
8,160 New
8,160 $2.35 Million
Q4 2022

Feb 13, 2023

BUY
$212.22 - $313.46 $13 Million - $19.2 Million
61,257 Added 606.69%
71,354 $21 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $341,392 - $427,804
1,520 Added 17.72%
10,097 $2.39 Million
Q2 2022

Aug 12, 2022

SELL
$186.4 - $279.02 $1.67 Million - $2.5 Million
-8,974 Reduced 51.13%
8,577 $1.87 Million
Q1 2022

May 13, 2022

SELL
$194.8 - $275.7 $607,776 - $860,184
-3,120 Reduced 15.09%
17,551 $4.68 Million
Q4 2021

Feb 14, 2022

SELL
$255.32 - $318.29 $1.2 Million - $1.49 Million
-4,688 Reduced 18.49%
20,671 $5.5 Million
Q3 2021

Nov 12, 2021

BUY
$260.36 - $307.27 $1.33 Million - $1.57 Million
5,101 Added 25.18%
25,359 $7.21 Million
Q2 2021

Aug 13, 2021

SELL
$225.52 - $304.06 $33.1 Million - $44.6 Million
-146,824 Reduced 87.88%
20,258 $5.56 Million
Q1 2021

May 14, 2021

BUY
$235.95 - $293.05 $24 Million - $29.9 Million
101,895 Added 156.31%
167,082 $43.6 Million
Q4 2020

Feb 12, 2021

BUY
$215.97 - $265.89 $9.34 Million - $11.5 Million
43,236 Added 196.97%
65,187 $16.7 Million
Q3 2020

Nov 12, 2020

SELL
$192.55 - $236.59 $1.17 Million - $1.43 Million
-6,060 Reduced 21.63%
21,951 $5.19 Million
Q2 2020

Aug 13, 2020

BUY
$159.17 - $224.73 $1.35 Million - $1.91 Million
8,505 Added 43.6%
28,011 $5.44 Million
Q1 2020

May 14, 2020

SELL
$130.01 - $216.44 $4.91 Million - $8.18 Million
-37,795 Reduced 65.96%
19,506 $3.23 Million
Q4 2019

Feb 14, 2020

BUY
$144.81 - $186.0 $8.3 Million - $10.7 Million
57,301 New
57,301 $9.7 Million
Q1 2019

May 15, 2019

SELL
$72.44 - $101.87 $4.32 Million - $6.08 Million
-59,680 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $175,115 - $251,404
2,390 Added 4.17%
59,680 $4.73 Million
Q3 2018

Nov 14, 2018

SELL
$81.43 - $108.13 $5.24 Million - $6.96 Million
-64,346 Reduced 52.9%
57,290 $6.07 Million
Q2 2018

Aug 14, 2018

BUY
$83.27 - $101.93 $661,496 - $809,731
7,944 Added 6.99%
121,636 $10.4 Million
Q1 2018

May 15, 2018

BUY
$68.49 - $87.2 $2.96 Million - $3.76 Million
43,173 Added 61.22%
113,692 $9.86 Million
Q4 2017

Feb 14, 2018

BUY
$55.67 - $71.8 $1.76 Million - $2.27 Million
31,671 Added 81.53%
70,519 $4.87 Million
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $1.34 Million - $1.61 Million
27,017 Added 228.36%
38,848 $2.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
11,831
11,831 $607,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.